Delivery Order SPE2DR25D3012-SPE2DR26F4B8J
- Not listed
- The Defense Logistics Agency awarded a $2,377.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Veklury (remdesivir), an antiviral medication used in medical treatment protocols. The contract, which is a child award under a larger indefinite delivery vehicle, was competitively awarded without set-aside designation and is scheduled for completion by May 12, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,962.20 to AmerisourceBergen Drug Corp for 100 mg vials of Veklury (remdesivir), a broad-spectrum antiviral medication. This firm fixed-price delivery order, issued on June 3, 2025, with an ultimate completion date of June 25, 2025, represents a non-competitive award under AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Veklury (remdesivir) 100 mg vials valued at $15,848.80 under a firm fixed-price contract. The award was issued on August 28, 2025, with an ultimate completion date of September 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Veklury (remdesivir) 100 mg vials, with a ceiling value of $5,010.48 and an ultimate completion date of December 1, 2025. This is a firm fixed-price delivery order awarded without set-aside designation, indicating competitive award based on the vendor's demonstrated capability to fulfill federal pharmaceutical procurement requirements. The place of performance is...
- This is a $13,618.40 delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a critical COVID-19 treatment medication. The firm-fixed-price contract runs through July 25, 2024 and was awarded on a full and open competition basis without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,754.64 for 100 mg vials of Veklury on September 12, 2025, with an ultimate completion date of October 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Veklury (remdesivir) is an antiviral medication used in the treatment of certain serious viral infections and represents part of...
- The Defense Logistics Agency awarded a delivery order valued at $11,886.30 to AmerisourceBergen Drug Corp for the supply of Veklury 100 mg vials, a critical antiviral medication. The contract is non-competitive, firm fixed-price delivery order with an ultimate completion date of September 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Veklury (Remdesivir) 100 mg vials. The $13,606.80 firm-fixed-price contract has an ultimate completion date of March 1, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $27,213.60 firm fixed-price delivery order is for the supply of VEKLURY (Remdesivir) 100 mg vials. The contract has a completion date of July 26, 2022 and does not include any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,924.40 on August 5, 2025, for the supply of Veklury 100 mg vials, an antiviral medication used in treating severe respiratory infections. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a non-competitive set-aside award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4B8JDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $5,010.48 firm fixed price delivery order for 100 mg vials of Veklury (remdesivir), a broad-spectrum antiviral medication, with a completion date of December 8, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical supply will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order reflects AmerisourceBergen's critical role as a pharmaceutical prime vendor supporting the Defense Health Agency and broader military healthcare systems. The company's comprehensive IDC serves as a global pharmaceutical support vehicle enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to military healthcare programs worldwide. The award demonstrates AmerisourceBergen's capability to fulfill federal medical procurement requirements through open competition and its established position within the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 11/14/25 |